Literature Citations
1. Antimicrobial Evaluation of Neutral and Cationic Iridium(III) and Rhodium(III) Aminoquinoline-benzimidazole Hybrid Complexes. Baartzes, N., A. Jordaan, D.F. Warner, J. Combrinck, D. Taylor, K. Chibale, and G.S. Smith. European Journal of Medicinal Chemistry, 2020. 206: 112694. PMID[32861176].
[PubMed]. TB_11_2020.
2. Antimicrobial and Antitubercular Evaluation of Some New 5-Amino-1,3,4-thiadiazole-2-thiol Derived Schiff Bases. Babu, K.A., I. Singhvi, N. Ravindra, and A.B. Shaik. Revue Roumaine de Chimie, 2020. 65(9): p. 771-776. ISI[000582609500001].
[WOS]. TB_11_2020.
3. Aureolic acid Group of Agents as Potential Antituberculosis Drugs. Bespyatykh, J., D. Bespiatykh, M. Malakhova, K. Klimina, A. Bespyatykh, A. Varizhuk, A. Tevyashova, T. Nikolenko, G. Pozmogova, E. Ilina, and E. Shitikov. Antibiotics, 2020. 9(10): p. 715. PMID[33086595]. PMCID[PMC7650759].
[PubMed]. TB_11_2020.
4. Gallium porphyrin and Gallium nitrate Synergistically Inhibit Mycobacterial Species by Targeting Different Aspects of Iron/heme Metabolism. Choi, S.R., B. Switzer, B.E. Britigan, and P. Narayanasamy. ACS Infectious Diseases, 2020. 6(10): p. 2582-2591. PMID[32845117].
[PubMed]. TB_11_2020.
5. Chemical Synthesis and Molecular Modeling of Novel Substituted N-1,3-Benzoxazol-2yl benzene Sulfonamides as Inhibitors of InhA Enzyme and Mycobacterium tuberculosis Growth. Chundawat, N.S., G.S. Shanbhag, and N.P.S. Chauhan. Journal of the Iranian Chemical Society, 2020. 18pp. ISI[000584541500001].
[WOS]. TB_11_2020.
6. Fragmentation Study, Dual Anti-bactericidal and Anti-viral Effects and Molecular Docking of Cobalt(III) Complexes. Fernandes, L.P., J.M.B. Silva, D.O.S. Martins, M.B. Santiago, C.H.G. Martins, A.C.G. Jardim, G.S. Oliveira, M. Pivatto, R.A.C. Souza, E.F. Franca, V.M. Deflon, A.E.H. Machado, and C.G. Oliveira. International Journal of Molecular Sciences, 2020. 21(21): p. 8355. PMID[33171773]. PMCID[PMC7664407].
[PubMed]. TB_11_2020.
7. InhA Inhibitors Have Activity against Non-replicating Mycobacterium tuberculosis. Flint, L., A. Korkegian, and T. Parish. Plos One, 2020. 15(11): e0239354. PMID[33201882]. PMCID[PMC7671525].
[PubMed]. TB_11_2020.
8. A Simple Work-up-free, Solvent-free Approach to Novel Amino Acid Linked 1,4-Disubstituted 1,2,3-triazoles as Potent Antituberculosis Agents. Garg, A., D. Borah, P. Trivedi, D. Gogoi, A.K. Chaliha, A.A. Ali, D. Chetia, V. Chaturvedi, and D. Sarma. ACS Omega, 2020. 5(46): p. 29830-29837. PMID[33251417]. PMCID[PMC7689670].
[PubMed]. TB_11_2020.
9. Structure-based Drug Repurposing to Inhibit the DNA Gyrase of Mycobacterium tuberculosis. Balasubramani, G.L., R. Rajput, M. Gupta, P. Dahiya, J.K. Thakur, R. Bhatnagar, and A. Grover. Biochemical Journal, 2020. 477(21): p. 4167-4190. PMID[33030198].
[PubMed]. TB_11_2020.
10. In Vitro and in Vivo Antimicrobial Activities of a Novel Piperazine-containing Benzothiazinones Candidate TZY-5-84 against Mycobacterium tuberculosis. Guo, S., L. Fu, B. Wang, X. Chen, J. Zhao, M. Liu, and Y. Lu. Biomedicine and Pharmacotherapy, 2020. 131: 110777. PMID[33152936].
[PubMed]. TB_11_2020.
11. Total Synthesis and Antimycobacterial Activity of Ohmyungsamycin A, Deoxyecumicin, and Ecumicin. Hawkins, P.M.E., W. Tran, G. Nagalingam, C.Y. Cheung, A.M. Giltrap, G.M. Cook, W.J. Britton, and R.J. Payne. Chemistry, 2020. 26(66): p. 15200-15205. PMID[32567168].
[PubMed]. TB_11_2020.
12. Leveraging Uncertainty in Machine Learning Accelerates Biological Discovery and Design. Hie, B., B.D. Bryson, and B. Berger. Cell Systems, 2020. 11(5): p. 461-477. PMID[33065027].
[PubMed]. TB_11_2020.
13. Endeavors Towards Transformation of M. tuberculosis Thymidylate Kinase (MtbTMPK) Inhibitors into Potential Antimycobacterial Agents. Jian, Y., R. Merceron, S. De Munck, H.E. Forbes, F. Hulpia, M.D.P. Risseeuw, K. Van Hecke, S.N. Savvides, H. Munier-Lehmann, H.I.M. Boshoff, and S. Van Calenbergh. European Journal of Medicinal Chemistry, 2020. 206: 112659. PMID[32823003].
[PubMed]. TB_11_2020.
14. Structure Elaboration of Isoniazid: Synthesis, in Silico Molecular Docking and Antimycobacterial Activity of Isoniazid-pyrimidine Conjugates. Kaur, H., L. Singh, K. Chibale, and K. Singh. Molecular Diversity, 2020. 24(4): p. 949-955. PMID[31691051].
[PubMed]. TB_11_2020.
15. Antimycobacterial Activity of Azepanobetulin and Its Derivative: In Vitro, in Vivo, ADMET and Docking Studies. Kazakova, O., T. Lopatina, G. Giniyatullina, M. Mioc, and C. Soica. Bioorganic Chemistry, 2020. 104: 104209. PMID[32911190].
[PubMed]. TB_11_2020.
16. Design and Synthesis of Purine Connected Piperazine Derivatives as Novel Inhibitors of Mycobacterium tuberculosis. Konduri, S., J. Prashanth, V.S. Krishna, D. Sriram, J.N. Behera, D. Siegel, and K.P. Rao. Bioorganic and Medicinal Chemistry Letters, 2020. 30(22): 127512. PMID[32871269].
[PubMed]. TB_11_2020.
17. Design, Synthesis and Biological Evaluation of Diamino Substituted Cyclobut-3-ene-1,2-dione Derivatives for the Treatment of Drug-resistant Tuberculosis. Li, P., B. Wang, G. Li, L. Fu, D. Zhang, Z. Lin, H. Huang, and Y. Lu. European Journal of Medicinal Chemistry, 2020. 206: 112538. PMID[32927218].
[PubMed]. TB_11_2020.
18. In Vitro Anti-mycobacterial Activity of Novel Benzo(C)thiophene-1,3-dione: A Novel Scaffold against Mycobacterium tuberculosis. Liu, F., J. Hu, L. Chang, and Y. Jiang. Microbial Pathogenesis, 2020. 148: 104466. PMID[32871256].
[PubMed]. TB_11_2020.
19. Artemisia annua and Artemisia afra Extracts Exhibit Strong Bactericidal Activity against Mycobacterium tuberculosis. Martini, M.C., T. Zhang, J.T. Williams, R.B. Abramovitch, P.J. Weathers, and S.S. Shell. Journal of Ethnopharmacology, 2020. 262: 113191. PMID[32730878]. PMCID[PMC7487009].
[PubMed]. TB_11_2020.
20. Novel Treatments against Mycobacterium tuberculosis Based on Drug Repurposing. Mourenza, Á., J.A. Gil, L.M. Mateos, and M. Letek. Antibiotics, 2020. 9(9): p. 550. PMID[32872158]. PMCID[PMC7557778].
[PubMed]. TB_11_2020.
21. Novel Anti-tubercular and Antibacterial Based Benzosuberone-thiazole Moieties: Synthesis, Molecular Docking Analysis, DNA Gyrase Supercoiling and ATPase Activity. Omar, M.A., G.S. Masaret, E.M.H. Abbas, M.M. Abdel-Aziz, M.F. Harras, and T.A. Farghaly. Bioorganic Chemistry, 2020. 104: 104316. PMID[33022549].
[PubMed]. TB_11_2020.
22. Alpha-Iodonitroalkenes as Potential Antifungal and Antitubercular Agents. Pamarthi, R., R. Kumar, C.S. Sankara, G.J. Lowe, J. Zuegg, S.K. Singh, and M. Ganesh. ChemistrySelect, 2020. 5(39): p. 12272-12277. ISI[000580579000031].
[WOS]. TB_11_2020.
23. Synthesis of New 3-Arylaminophthalides and 3-Indolyl-phthalides Using Ammonium Chloride, Evaluation of their Anti-mycobacterial Potential and Docking Study. Patil, A., H. Duggal, K.T. Bagul, S. Kamble, P. Lokhande, R. Gacche, and R. Meshram. Combinatorial Chemistry and High Throughput Screening, 2020. 23(8): p. 723-739. PMID[32321396].
[PubMed]. TB_11_2020.
24. Antimicrobial Peptide against Mycobacterium tuberculosis That Activates Autophagy Is an Effective Treatment for Tuberculosis. Peláez Coyotl, E.A., J. Barrios Palacios, G. Muciño, D. Moreno-Blas, M. Costas, T. Montiel Montes, C. Diener, S. Uribe-Carvajal, L. Massieu, S. Castro-Obregón, O.R. Espinosa, D. Mata Espinosa, J. Barrios-Payan, J.C. León Contreras, G. Corzo, R. Hernández-Pando, and G. Del Rio. Pharmaceutics, 2020. 12(11): p. 1071. PMID[33182483]. PMCID[PMC7697726].
[PubMed]. TB_11_2020.
25. Design and Synthesis of New Indanol-1,2,3-triazole Derivatives as Potent Antitubercular and Antimicrobial Agents. Phatak, P.S., R.D. Bakale, R.S. Kulkarni, S.T. Dhumal, P.P. Dixit, V.S. Krishna, D. Sriram, V.M. Khedkar, and K.P. Haval. Bioorganic and Medicinal Chemistry Letters, 2020. 30(22): 127579. PMID[32987135].
[PubMed]. TB_11_2020.
26. MoS(2)-Calix[4]arene Catalyzed Synthesis and Molecular Docking Study of 2,4,5-Trisubstituted Imidazoles as Potent Inhibitors of Mycobacterium tuberculosis. Raghu, M.S., C.B. Pradeep Kumar, K.N.N. Prasad, M.K. Prashanth, Y.K. Kumarswamy, S. Chandrasekhar, and B. Veeresh. ACS Combinatorial Science, 2020. 22(10): p. 509-518. PMID[32806898].
[PubMed]. TB_11_2020.
27. Design and Synthesis of 4-Aminoquinoline-isoindoline-dione-isoniazid Triads as Potential Anti-mycobacterials. Rani, A., M.D. Johansen, F. Roquet-Banères, L. Kremer, P. Awolade, O. Ebenezer, P. Singh, Sumanjit, and V. Kumar. Bioorganic and Medicinal Chemistry Letters, 2020. 30(22): 127576. PMID[32980514].
[PubMed]. TB_11_2020.
28. Discovery of Prenyltransferase Inhibitors with in Vitro and in Vivo Antibacterial Activity. Song, J., S.R. Malwal, N. Baig, L.A. Schurig-Briccio, Z. Gao, G.S. Vaidya, K. Yang, N.S. Abutaleb, M.N. Seleem, R.B. Gennis, T.V. Pogorelov, E. Oldfield, and X. Feng. ACS Infectious Diseases, 2020. 6(11): p. 2979-2993. PMID[33085463].
[PubMed]. TB_11_2020.
29. 6,11-Dioxobenzo[F]pyrido[1,2-a]indoles Kill Mycobacterium tuberculosis by Targeting Iron-sulfur Protein Rv0338c (IspQ), a Putative Redox Sensor. Székely, R., M. Rengifo-Gonzalez, V. Singh, O. Riabova, A. Benjak, J. Piton, M. Cimino, E. Kornobis, V. Mizrahi, K. Johnsson, G. Manina, V. Makarov, and S.T. Cole. ACS Infectious Diseases, 2020. 6(11): p. 3015-3025. PMID[32930569].
[PubMed]. TB_11_2020.
30. Design, Synthesis, in Silico and in Vitro Evaluation of Novel Diphenyl Ether Derivatives as Potential Antitubercular Agents. Tiwari, A.P., B. Sridhar, H.I. Boshoff, K. Arora, G. Gautham Shenoy, K.E. Vandana, and G. Varadaraj Bhat. Molecular Diversity, 2020. 24(4): p. 1265-1279. PMID[31506871].
[PubMed]. TB_11_2020.
31. Sirtuin Inhibits M. tuberculosis-induced Apoptosis in Macrophage through Glycogen Synthase Kinase-3β. Yang, H., J. Chen, Y. Chen, Y. Jiang, B. Ge, and L. Hong. Archives of Biochemistry and Biophysics, 2020. 694: 108612. PMID[33007281].
[PubMed]. TB_11_2020.
32. Nonpeptidal Compounds from the Insect Polyphaga plancyi and their Biological Evaluation. Zhu, H.J., T. Xu, Y.M. Yan, and Y.X. Cheng. Bioorganic Chemistry, 2020. 104: 104258. PMID[32956876].
[PubMed]. TB_11_2020.
Patent Citations
This month, no relevant Mycobacterium patents were identified.